Erika Spens currently serves as the VP of Regulatory Affairs at Scandinavian Biopharma since November 2024. Prior to this role, Erika was the Senior Director of Regulatory Affairs at SDS Life Science - a Cytel company from May 2021 to November 2024, leading a team that supported small and medium-sized companies in navigating US and EU regulatory environments. Erika held the position of Director of Global Regulatory Affairs Haematology at Sobi from October 2017 to May 2021, overseeing new marketing authorization applications and post-marketing activities across various regions. Previous experience includes roles as Program Manager and CMC Specialist at Bioarctic AB, where Erika managed clinical projects and external manufacturing. Erika's career began at Biovitrum as a Cell Culture Specialist focused on biopharmaceutical process development. Erika holds a PhD in Bioprocess Technology from KTH Royal Institute of Technology and an MSc in Molecular Biotechnology from Uppsala University.
This person is not in any offices